Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03127137 · ClinicalTrials.gov registry record · Phase 4
CESI With Low Dose Lidocaine and Transient Weakness
A Phase 4 study, sponsored by Northwestern University.
- Completed
- Registry status
- Phase 4
- Development phase
- 123
- Enrollment target
NCT03127137 is a Phase 4 study that has completed, run by Northwestern University. The registered enrollment target is 123 participants.
The verdict
NCT03127137, a Phase 4 study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 123 participants
- Enrollment target
Study Summary
Cervical radicular pain is relatively common, often treated with epidural steroid injection (ESI), when conservative treatments like oral analgesics, physical therapy and activity modification have failed. There are no universal clinical practice guidelines for the use of diluents when CESI are performed. Interlaminar CESI may be performed with or without the use of local anesthetics, due to training bias or theoretical concerns of weakness. CESI without the benefit of local anesthetic as a steroid diluent increases the latency of pain relief and may decrease diagnostic information immediately after a CESI with regard to pain generators responsible for symptoms, and may potentially decrease patient satisfaction. By evaluating the effects of local anesthetic as a diluent during interlaminar cervical ESI, we will enhance the safety of this treatment with regard to expectations of objective motor weakness as well as post procedure pain control and patient satisfaction in the recovery phase after the injection procedure. Research Question: Does lidocaine versus saline as a steroid diluent effect objective upper extremity strength following cervical epidural steroid injection in patients being treated for cervical radiculitis? Null Hypothesis: Cervical epidural steroid injections that include local anesthetic as a diluent have no effect on objective upper extremity strength following the injection. We hypothesized that cervical epidural lidocaine will cause an objective decrease in strength in functional movements of the upper extremity.
Interventions
- DRUG Experimental Group 1 triamcinolone and lidocaine
- DRUG Experimental Group 2 triamcinolone and saline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 123 participants |
| Start Date | 2018-08-01 |
| Est. Completion | 2019-06-15 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03127137
The ClinicalTrials.gov registry entry for NCT03127137 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 123 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Experimental Group 1 triamcinolone and lidocaine is the first listed.
NCT03127137 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03127137 about?
NCT03127137 is a clinical study titled "CESI With Low Dose Lidocaine and Transient Weakness". Cervical radicular pain is relatively common, often treated with epidural steroid injection (ESI), when conservative treatments like oral analgesics, physical therapy and activity modification have failed. There are no universal clinical practice guidelines for the use of diluents when CESI are perf...
What is the current status of trial NCT03127137?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 123 participants. The study started on 2018-08-01. Estimated completion is 2019-06-15.
What interventions are being tested in trial NCT03127137?
The interventions under investigation include: Experimental Group 1 triamcinolone and lidocaine (DRUG), Experimental Group 2 triamcinolone and saline (DRUG).
Who is sponsoring clinical trial NCT03127137?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.